DNA mismatch repair and oxidative DNA damage: Implications for cancer biology and treatment

Cancers

Volumn 6, Issue 3, 2014, Pages 1597-1614

  Bridge, Gemma ^a   Rashid, Sukaina ^a   Martin, Sarah A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chemotherapeutics; Mismatch repair; Mitochondria; Oxidative DNA damage; ROS

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTHRACYCLINE DERIVATIVE; ASCORBIC ACID; BETA CAROTENE; BETA LAPACHONE; CAMPTOTHECIN DERIVATIVE; CARBOPLATIN; CISPLATIN; DIMETHYLAMINOPARTHENOLIDE; DNA; EPIPODOPHYLLOTOXIN DERIVATIVE; LACTONE DERIVATIVE; METHOTREXATE; METHYLSELENINIC ACID; MITOCHONDRIAL DNA; MOLYBDENUM; PARTHENOLIDE; PLACEBO; PLATINUM COMPLEX; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; SELENIUM DERIVATIVE; UBIDECARENONE; UNCLASSIFIED DRUG; ZINC;

ANTIOXIDANT ACTIVITY; BREAST CANCER; CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL POLYP; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; DRUG SELECTIVITY; DRUG TARGETING; ENDOMETRIUM CANCER; EXCISION REPAIR; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IONIZING RADIATION; LIVER CELL CARCINOMA; METASTATIC COLORECTAL CANCER; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MITOCHONDRIAL GENOME; MUTATOR GENE; NEOPLASM; NONHUMAN; OVARY CANCER; OXIDATIVE DNA DAMAGE; OXIDATIVE STRESS; REVIEW; SINGLE STRANDED DNA BREAK; SOMATIC MUTATION; TRIPLE NEGATIVE BREAST CANCER;

EID: 84928822333     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers6031597     Document Type: Review

References (75)

1. Dizdaroglu, M. Oxidatively induced DNA damage: Mechanisms, repair and disease. Cancer Lett. 2012, 327, 26-47.
2. Yang, Y.; Bazhin, A.V.; Werner, J.; Karakhanova, S. Reactive oxygen species in the immune system. Int. Rev. Immunol. 2013, 32, 249-270.
3. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine, 4th ed.; Oxford University Press: New York, NY, USA, 2007.
4. Storr, S.J.; Woolston, C.M.; Martin, S.G. Base excision repair, the redox environment and therapeutic implications. Curr. Mol. Pharmacol. 2012, 5, 88-101.
5. Lu, A.L.; Li, X.; Gu, Y.; Wright, P.M.; Chang, D.Y. Repair of oxidative DNA damage: Mechanisms and functions. Cell Biochem. Biophys. 2001, 35, 141-170.
6. Greenman, C.; Stephens, P.; Smith, R.; Dalgliesh, G.L.; Hunter, C.; Bignell, G.; Davies, H.; Teague, J.; Butler, A.; Stevens, C.; et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446, 153-158.
7. Olivier, M.; Hollstein, M.; Hainaut, P. TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2010, 2, a001008.
8. Roberts, S.A.; Lawrence, M. S.; Klimczak, L.J.; Grimm, S. A.; Fargo, D.; Stojanov, P.; Kiezun, A.; Kryukov, G.V.; Carter, S.L.; Saksena, G.; et al. An. APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 2013, 45, 970-976.
9. Konturek, P.C.; Konturek, S.J.; Brzozowski, T. Gastric cancer and Helicobacter pylori infection. J. Physiol. Pharmacol. 2006, 57, S51-S65.
10. Seril, D.N.; Liao, J.; Yang, G.; Yang, C.S. Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in humans and animal models. Carcinogenesis 2003, 24, 353-362.
11. Kryston, T.B.; Georgiev, A.B.; Pissis, P.; Georgakilas, A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat. Res. 2011, 711, 193-201.
12. Olinski, R.; Gackowski, D.; Rozalski, R.; Foksinski, M.; Bialkowski, K. Oxidative DNA damage in cancer patients: A cause or a consequence of the disease development? Mutat. Res. Fundam. Mol. Mech. Mut. 2003, 531, 177-190.
13. Kim, Y.J.; Wilson, D.M., 3rd. Overview of base excision repair biochemistry. Curr. Mol. Pharmacol. 2012, 5, 3-13.
14. Kamileri, I.; Karakasilioti, I.; Garinis, G.A. Nucleotide excision repair: New tricks with old bricks. Trends Genet. 2012, 28, 566-573.
15. Lin, J.J.; Sancar, A. A new mechanism for repairing oxidative damage to DNA: (A)BC excinuclease removes AP sites and thymine glycols from DNA. Biochemistry 1989, 28, 7979-7984.
16. Reardon, J.T.; Bessho, T.; Kung, H.C.; Bolton, P.H.; Sancar, A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. USA 1997, 94, 9463-9468.
17. Brooks, P.J.; Wise, D.S.; Berry, D.A.; Kosmoski, J.V.; Smerdon, M.J.; Somers, R.L.; Mackie, H.; Spoonde, A.Y.; Ackerman, E.J.; Coleman, K. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 2000, 275, 22355-22362.
18. Kuraoka, I.; Bender, C.; Romieu, A.; Cadet, J.; Wood, R.D.; Lindahl, T.. Removal of oxygen free-radical-induced 5',8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl. Acad. Sci. USA 2000, 97, 3832-3837.
19. Macpherson, P.; Barone, F.; Maga, G.; Mazzei, F.; Karran, P.; Bignami, M. 8-oxoguanine incorporation into DNA repeats in vitro and mismatch recognition by MutSalpha. Nucleic Acids Res. 2005, 33, 5094-5105.
20. Li, G.M. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008, 18, 85-98.
21. Genschel, J.; Littman, S.J.; Drummond, J.T.; Modrich, P. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J. Biol. Chem. 1998, 273, 19895-19901.
22. Kolodner, R.D.; Marsischky, G.T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 1999, 9, 89-96.
23. Cannavo, E.; Marra, G.; Sabates-Bellver, J.; Menigatti, M.; Lipkin, S. M.; Fischer, F.; Cejka, P.; Jiricny, J. Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cancer Res. 2005, 65, 10759-10766.
24. Kunkel, T.A.; Erie, D.A. DNA mismatch repair. Annu. Rev. Biochem. 2005, 74, 681-710.
25. Li, G.M.; Modrich, P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. USA 1995, 92, 1950-1954.
26. Plotz, G.; Raedle, J.; Brieger, A.; Trojan, J.; Zeuzem, S. hMutSalpha forms an ATP-dependent complex with hMutLalpha and hMutLbeta on DNA. Nucleic Acids Res. 2002, 30, 711-718.
27. Jiricny, J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006, 7, 12.
28. Martin, S.A.; Lord, C.J.; Ashworth, A. Therapeutic targeting of the DNA mismatch repair pathway. Clin. Cancer Res. 2010, 16, 5107-5113.
29. Brierley, D.J.; Martin, S.A. Oxidative stress and the DNA mismatch repair pathway. Antioxid. Redox Signal. 2013, 18, 2420-2428.
30. Russo, M.T.; De Luca, G.; Degan, P.; Bignami, M. Different DNA repair strategies to combat the threat from 8-oxoguanine. Mutat. Res. 2007, 614, 69-76.
31. Imai, K.; Yamamoto, H. Carcinogenesis and microsatellite instability: The interrelationship between genetics and epigenetics. Carcinogenesis 2008, 29, 673-680.
32. Popat, S.; Hubner, R.; Houlston, R.S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 2005, 23, 609-618.
33. Resnick, K.E.; Frankel, W.L.; Morrison, C.D.; Fowler, J.M.; Copeland, L.J.; Stephens, J.; Kim, K.H.; Cohn, D.E. Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer. Gynecol. Oncol. 2010, 117, 234-238.
34. Xiao, X.; Melton, D.W.; Gourley, C. Mismatch repair deficiency in ovarian cancer-Molecular characteristics and clinical implications. Gynecol. Oncol. 2014, 132, 506-512.
35. Hewish, M.; Lord, C.J.; Martin, S.A.; Cunningham, D.; Ashworth, A. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat. Rev. Clin. Oncol. 2010, 7, 197-208.
36. Karamurzin, Y.; Rutgers, J.K. DNA mismatch repair deficiency in endometrial carcinoma. Int. J. Gynecol. Pathol. 2009, 28, 239-255.
37. Lynch, H.T.; Lynch, J.F.; Lynch, P.M.; Attard, T. Hereditary colorectal cancer syndromes: Molecular genetics, genetic counseling, diagnosis and management. Fam. Cancer 2008, 7, 27-39.
38. Bhattacharyya, N.P.; Skandalis, A.; Ganesh, A.; Groden, J.; Meuth, M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl. Acad. Sci. USA 1994, 91, 6319-6323.
39. Parsons, R.; Li, G.M.; Longley, M.J.; Fang, W.H.; Papadopoulos, N.; Jen, J.; de la Chapelle, A.; Kinzler, K.W.; Vogelstein, B.; Modrich P. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993, 75, 1227-1236.
40. Johannsdottir, J.T.; Jonasson, J.G.; Bergthorsson, J.T.; Amundadottir, L.T.; Magnusson, J.; Egilsson, V.; Ingvarsson, S. The effect of mismatch repair deficiency on tumourigenesis; microsatellite instability affecting genes containing short repeated sequences. Int. J. Oncol. 2000, 16, 133-139.
41. Colussi, C.; Parlanti, E.; Degan, P.; Aquilina, G.; Barnes, D.; Macpherson, P.; Karran, P.; Crescenzi, M.; Dogliotti, E.; Bignami, M. The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr. Biol. 2002, 12, 912-918.
42. DeWeese, T.L.; Shipman, J.M.; Larrier, N.A.; Buckley, N.M.; Kidd, L.R.; Groopman, J.D.; Cutler, R.G.; te Riele, H.; Nelson, W.G. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proc. Natl. Acad. Sci. USA 1998, 95, 11915-11920.
43. Sakumi, K.; Furuichi, M.; Tsuzuki, T.; Kakuma, T.; Kawabata, S.; Maki, H.; Sekiguchi, M. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J. Biol. Chem. 1993, 268, 23524-23530.
44. Wang, G.; Alamuri, P.; Humayun, M.Z.; Taylor, D.E.; Maier, R.J. The Helicobacter pylori MutS protein confers protection from oxidative DNA damage. Mol. Microbiol. 2005, 58, 166-176.
45. Mazurek, A.; Berardini, M.; Fishel, R. Activation of human MutS homologs by 8-oxo-guanine DNA damage. J. Biol. Chem. 2002, 277, 8260-8266.
46. Ni, T.T.; Marsischky, G.T.; Kolodner, R.D. MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae. Mol. Cell 1999, 4, 439-444.
47. Sage, E.; Harrison, L. Clustered DNA lesion repair in eukaryotes: Relevance to mutagenesis and cell survival. Mutat. Res. 2011, 711, 123-133.
48. Holt, S.M.; Scemama, J.L.; Panayiotidis, M.I.; Georgakilas, A.G. Compromised repair of clustered DNA damage in the human acute lymphoblastic leukemia MSH2-deficient NALM-6 cells. Mutat. Res. 2009, 674, 123-130.
49. Zlatanou, A.; Despras, E.; Braz-Petta, T.; Boubakour-Azzouz, I.; Pouvelle, C.; Stewart, G.S.; Nakajima, S.; Yasui, A.; Ishchenko, A.A.; Kannouche, P.L. The hMsh2-hMsh6 complex acts in concert with monoubiquitinated PCNA and Pol eta in response to oxidative DNA damage in human cells. Mol. Cell 2011, 43, 649-662.
50. Barone, F.; McCulloch, S.D.; Macpherson, P.; Maga, G.; Yamada, M.; Nohmi, T.; Minoprio, A.; Mazzei, F; Kunkel, T.A.; Karran, P.; et al. Replication of 2-hydroxyadenine-containing DNA and recognition by human MutSα. DNA Repair 2007, 6, 355-366.
51. Russo, M.T.; De Luca, G.; Casorelli, I.; Degan, P.; Molatore, S.; Barone, F.; Mazzei, F.; Pannellini, T.; Musiani, P.; Bignami, M. Role of MUTYH and MSH2 in the Control. of Oxidative DNA Damage, Genetic Instability, and Tumorigenesis. Cancer Res. 2009, 69, 4372-4379.
52. Gu, Y.; Parker, A.; Wilson, T. M.; Bai, H.; Chang, D. Y.; Lu, A. L. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J. Biol. Chem. 2002, 277, 11135-11142.
53. Tuppen, H.A.L.; Blakely, E.L.; Turnbull, D.M.; Taylor, R.W. Mitochondrial DNA mutations and human disease. Biochim. Biophys. Acta (BBA)-Bioenerg. 2010, 1797, 113-128.
54. Svilar, D.; Goellner, E.M.; Almeida, K.H.; Sobol, R.W. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid. Redox Signal. 2011, 14, 2491-2507.
55. Habano, W.; Nakamura, S.; Sugai, T. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: Evidence for mismatch repair systems in mitochondrial genome. Oncogene 1998, 17, 1931-1937.
56. Reenan, R.A.; Kolodner, R.D. Characterization of insertion mutations in the Saccharomyces cerevisiae MSH1 and MSH2 genes: Evidence for separate mitochondrial and nuclear functions. Genetics 1992, 132, 975-985.
57. Hashiguchi, K.; Bohr, V.A.; de Souza-Pinto, N.C. Oxidative stress and mitochondrial DNA repair: Implications for NRTIs induced DNA damage. Mitochondrion 2004, 4, 215-222.
58. De Souza-Pinto, N.C.; Mason, P.A.; Hashiguchi, K.; Weissman, L.; Tian, J.; Guay, D.; Lebel, M.; Stevnsner, T.V.; Rasmussen, L.J.; Bohr, V.A. Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair (Amst.) 2009, 8, 704-719.
59. Martin, S.A.; McCabe, N.; Mullarkey, M.; Cummins, R.; Burgess, D.J.; Nakabeppu, Y.; Oka, S.; Kay, E.; Lord, C. J.; Ashworth, A. DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1. Cancer Cell 2010, 17, 235-248.
60. Mootha, V.K.; Bunkenborg, J.; Olsen, J.V.; Hjerrild, M.; Wisniewski, J.R.; Stahl, E.; Bolouri, M.S.; Ray, H.N.; Sihag, S.; Kamal, M.; et al. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 2003, 115, 629-640.
61. Martin, S.A.; Hewish, M.; Sims, D.; Lord, C.J.; Ashworth, A. Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers. Cancer Res. 2011, 71, 1836-1848.
62. Glaab, W.E.; Hill, R.B.; Skopek, T.R. Suppression of spontaneous and hydrogen peroxide-induced mutagenesis by the antioxidant ascorbate in mismatch repair-deficient human colon cancer cells. Carcinogenesis 2001, 22, 1709-1713.
63. Hardman, R.A.; Afshari, C.A.; Barrett, J.C. Involvement of Mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress. Cancer Res. 2001, 61, 1392-1397.
64. Martin, S.A.; McCarthy, A.; Barber, L.J.; Burgess, D.J.; Parry, S.; Lord, C.J.; Ashworth, A. Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2. EMBO Mol. Med. 2009, 1, 323-337.
65. Piao, J.; Nakatsu, Y.; Ohno, M.; Taguchi, K.; Tsuzuki, T. Mismatch repair deficient mice show susceptibility to oxidative stress-induced intestinal carcinogenesis. Int. J. Biol. Sci. 2013, 10, 73-79.
66. Gorrini, C.; Harris, I.S.; Mak, T.W. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 2013, 12, 931-947.
67. Chiu, W.H.; Luo, S.J.; Chen, C.L.; Cheng, J.H.; Hsieh, C.Y.; Wang, C.Y.; Huang, W.C.; Su, W.C.; Lin, C.F. Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells. Biochem. Pharmacol. 2012, 83, 1159-1171.
68. Conklin, K.A. Chemotherapy-associated oxidative stress: Impact on chemotherapeutic effectiveness. Integr. Cancer Ther. 2004, 3, 294-300.
69. D'Anneo, A.; Carlisi, D.; Lauricella, M.; Puleio, R.; Martinez, R.; Di Bella, S.; Di Marco, P.; Emanuele, S.; di Fiore, R.; Guercio, A; et al. Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer. Cell Death Dis. 2013, 4, e891.
70. Zhang, Y.; Zheng, S.; Zheng, J.S.; Wong, K.H.; Huang, Z.; Ngai, S.M.; Zheng, W.; Wong, Y.S.; Chen, T. Synergistic induction of apoptosis by methylseleninic acid and cisplatin, the role of ROS-ERK/AKT-p53 pathway. Mol. Pharm. 2014, 11, 1282-1293
71. Huang, X.; Dong, Y.; Bey, E.A.; Kilgore, J.A.; Bair, J.S.; Li, L.S.; Patel, M.; Parkinson, E.I.; Wang, Y.; Williams, N. S.; et al. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis. Cancer Res. 2012, 72, 3038-3047.
72. Liu, J.F.; Konstantinopoulos, P.A.; Matulonis, U.A. PARP inhibitors in ovarian cancer: Current status and future promise. Gynecol. Oncol. 2014, 133, 362-369.
73. Hewish, M.; Martin, S.A.; Elliott, R.; Cunningham, D.; Lord, C.J.; Ashworth, A. Cytosine-Based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress. Br. J. Cancer 2013, 108, 983-992.
74. Dwyer, D.J.; Belenky, P.A.; Yang, J.H.; MacDonald, I.C.; Martell, J.D.; Takahashi, N.; Chan, C.T.Y.; Lobritz, M.A.; Braff, D.; Schwarz, E.G.; et al. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc. Natl. Acad. Sci. USA 2014, 10.1073/pnas.1401876111
75. Mendelsohn, A.R.; Larrick, J.W. Paradoxical effects of antioxidants on cancer. Rejuvenation Res. 2014, 17, 306-311.